Our dynamic growth is driven by bold strategic partnerships in research & development, licensing, and distribution.
We collaborate with pharmaceutical players in Switzerland, Europe, and globally to complement the healthcare offering, making it accessible to as many patients as possible through the generic status of our medications.
Additionally, we position ourselves as a distribution partner in the Swiss market, where we provide reference treatments of well-established products whose therapeutic benefits are widely recognized by healthcare professionals.
We build strong relationships with wholesalers, hospitals, and pharmacies to ensure continuous access to our products, both in local Swiss and European markets as well as internationally. We are committed to responding promptly to ensure supply continuity and optimal customer satisfaction.
In partnership with trusted collaborators in Switzerland and Europe, we guarantee that our products are efficiently delivered from manufacturers to points of sale.
We provide essential pharmaceutical products affordably through generic or hybrid statuses across many therapeutic areas, often as the sole generic provider in the Swiss market.
This enables our partners to offer high-quality options recognized as standards of care in medical practice, while actively contributing to reducing healthcare costs for patients.
With over 30 product references available in Switzerland and more across Europe, we provide our partners with comprehensive support. This includes ensuring regulatory compliance for safe commercialization, fully aligned with local, Swiss, European, and international requirements.
Development, acquisition, licensing-in, and licensing-out
From obtaining marketing authorizations to price validation and reimbursement approval
Maintenance of marketing authorization dossiers, quality management, and pharmacovigilance oversight
From production orders to the delivery of medications to hospitals and pharmacies
Implementation of commercial and marketing strategies, including promotion to specialists and pharmacists
Leman SKL Pharmaceuticals holds nearly 60 marketing authorizations in Switzerland and Europe for hospital, prescription, and OTC medications.
place their trust in us, collaborating with us at every stage of the medication lifecycle, from research and development to its availability in hospitals or pharmacies.
with a strong concentration of our manufacturing sites also located within the continent.
To provide the best reference treatments in every market where we operate, we also partner with strategic collaborators across other continents.
We leverage our expertise and network to achieve shared goals. From the development of therapeutic solutions to the registration of medications and market access, we have in-depth knowledge of our markets and assets, enabling us to effectively promote our products to healthcare professionals.
Our top priority in every partnership is to ensure optimized go-to-market and time-to-market strategies.
As an independent and agile company, Leman SKL Pharmaceuticals is dedicated to providing tailored solutions that meet the specific needs of each of our partners.
The Leman SKL Pharmaceuticals Group is firmly established in Europe, with subsidiaries in Paris and Milan, and extends its reach internationally through strategic bases in Hong Kong and Mexico. From its headquarters in Switzerland, the company oversees its global operations, ensuring consistency and excellence across all its activities worldwide.
The company has plans for further expansion, aiming to enhance its international reach in the near future.
LABORATOIRES MEDGEN SAS
24 Rue Erlanger, 75016 Paris
FRANCE
LEMAN SKL SA
Route de Chancy 15,
1213 Petit-Lancy
SWITZERLAND
LEMAN SKL SRL
Largo Augusto 8
Milano 20122
ITALY
LEMAN SKL SRL DE CV
Londres 24-PISO 4
Col. Juárez, Cuauhtémoc,
C.P. 06600, Ciudad de México
MEXICO
LEMAN SKL LIMITED
21/F, On Hing Building,
1 On Hing Terrace, Central
HONG KONG
